51
Optimizing One-Lung Ventilation Philip Hartigan, M.D. 11/25/11 Kuwait

Optimizing One-Lung Ventilation Philip Hartigan , M.D. 11/25/11 Kuwait

  • Upload
    urbana

  • View
    100

  • Download
    0

Embed Size (px)

DESCRIPTION

Optimizing One-Lung Ventilation Philip Hartigan , M.D. 11/25/11 Kuwait. The Balancing Act of One-Lung Ventilation. O 2. CO 2. Injury. The essence of efficient g as exchange i s Ventilation –Perfusion Matching. Multiple Inert Gas Elimination Technique. West.JB: Resp Physiology. - PowerPoint PPT Presentation

Citation preview

Page 1: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

OptimizingOne-Lung Ventilation

Philip Hartigan, M.D.11/25/11Kuwait

Page 2: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

CO2

Injury

The Balancing Act ofOne-Lung Ventilation

O2

Page 3: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

The essence of efficientgas exchange

is Ventilation –Perfusion

Matching

Page 4: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 5: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

West.JB: Resp Physiology

Multiple Inert Gas Elimination Technique

Page 6: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

West.JB: Resp Physiology

Multiple Inert Gas Elimination Technique

HPV

Page 7: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

West.JB: Resp Physiology

Multiple Inert Gas Elimination Technique

HPV

Gravity

Page 8: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

West.JB: Resp Physiology

Multiple Inert Gas Elimination Technique

HPV

Gravity

Anatomy

Page 9: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

MIGET during OLV

Page 10: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 11: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

HPV & Gravity

Page 12: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 13: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

R/O Obstruction

Page 14: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

CPAP

Page 15: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

PEEPRecruit

Page 16: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Hypoxia During OLV

FiO2 = 1.0 R/O Obstruction/Malposition Reinflation Recruit/PEEP to Dependent

Lung CPAP to Nondependent Lung PA Crossclamp

Page 17: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Optimal PEEP ?

Page 18: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 19: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 20: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

{

Page 21: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 22: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 23: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 24: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Choice of Agent & PaO2 during OLV

Pagel ‘98 (humans) Desfl = IsoflSchwarzkopf ‘03 (pigs) Desfl = IsoflWang ‘98 (humans) Isofl = SevoSaito ‘00 (humans) Isofl = SevoShimizu ‘98 (humans) Isofl = SevoAbe ‘98 (humans) Isofl = SevoSlinger ‘95 (humans) Isofl > Enfl

Page 25: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 26: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Dose of Volatile Agents and PaO2 during OLV

Schwarzkopf, Anesth Analg, 93:1434, 2001

Page 27: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 28: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

TIVA vs Volatile Anesthesia

PaO2 during OLV

Reid ‘96 (30 Pts) Prop/Alf = IsoKarzai ‘98 (10 pigs) Prop > DesAbe ‘98 (20 Pts) Prop > Iso/DesBeck ‘01 (40 Pts) Prop = SevoDossow ‘01 (50 Pts) Prop/Fent > TEA/IsoSchwarzkopf ‘03 (30 pigs) Prop >Des/IsoPruszkowski ‘07 (80 Pts) Prop =SevoSchwarzkopf ‘09 (60 Pts) Prop =Sevo

Page 29: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

PaCO2 (mmHg) 35 + 5 35 + 4 36 + 1PaO2 (mmHg) 196 + 70† 133 + 58 126 + 57PvO2 (mmHg) 40 + 5* 37 + 5 36 + 5Qs/Qt (%) 23 + 7 25 + 7 26 + 5

RL Perfusion (%) 19 + 7 20 + 7 18 + 6CO (L/min) 5.4 + 2§, ‡ 4.4 + 1 5.0 + 2

Schwarzkopf K; J Cardiothoracic Vasc Anesth 2003;17(1):73

TIVA vs Volatile Agents

Prop Desfl Isofl

Page 30: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 31: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 32: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

iNO and Oxygenation During OLV

Reference n NO PPM PaO2

Hartigan 36 20 No ChangeAnesthesiology 1996

Page 33: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

iNO and Oxygenation During OLV

Reference n NO PPM PaO2

Hartigan 36 20 No ChangeAnesthesiology 1996Wilson 6 40 No ChangeJ. Cardioth Vasc Anesth 1997

Ismail – Zade 12 3-5 No ChangeJ. Cardioth Vasc Anesth 1997Moutafis 20 20 No ChangeAnesth Analg 1997

Fradj 60 20 No ChangeBr J Anaesth 1998Schwarzkopf 152 20 No ChangeAnesth Analg 2001Della Rocca 30 40 No ChangeJ. Cardioth Vasc Anesth 2001

Page 34: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode

Page 35: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

PCV vs VCV for OLV

Tugrul ’97 PCV > VCV(n=48, Crossover, VT=10ml/kg)

Heimberg ’06 PCV = VCV(n=50, No Crossover, VT=10ml/kg)

Unzuetta ’07 PCV = VCV(n=57, Crossover, VT=9ml/kg)

Page 36: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 37: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 38: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Dose of Volatile Agents and PaO2 during OLV

Schwarzkopf, Anesth Analg, 93:1434, 2001

14 Pigs – Anesth / Para, OLV, LLD

Varied Dose of Isofl & Desfl (0.5 – 1.0 – 1.5 MAC)

Measured: Qs/Qt, CO, PvO2, PaO2, % Q-R-Lung

Page 39: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Schwarzkopf, Anesth Analg, 93:1434, 2001

Dose of Volatile Agents and PaO2 during OLV

Page 40: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

12 Pigs – Anesth / Para, OLV, LLD Initially Remifent + N2O, then:

Isoflurane 1 MAC Desflurane 1 MAC Propofol - adjusted to equivalent

BP/HR Measurements:

Qs/Qt, PaO2, PVO2, %Q-R-Lung, Hemodyn.

TIVA vs Volatile AgentsSchwarzkopf K; J Cardiothorac Vasc Anesth 17: 73, 2003

Page 41: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Advantages of PCV

Decelerating Flow Pattern

Improved Recruitment of Slow Alveoli

More Homogeneous Ventilation

Better V/Q Matching (?)

Lower PIP’s

Page 42: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode Position Thoracic Epidural Cardiac Output

Page 43: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Lateral > Prone > Supine

PaO2 during OLV: Effect of Position

Page 44: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode Position Thoracic Epidural Cardiac Output

Page 45: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Beyond CPAP & PEEP ?

Choice of Volatile Agent Dose of Volatile Agent TIVA Inhaled Nitric Oxide Ventilator Mode Position Thoracic Epidural Cardiac Output

Page 46: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Effect of C.O. on PaO2

during OLV

PaO2

Perfusion of Nondependent Lung

P.A. Pressure Counteracts HPV

Mixed Venous O2

Page 47: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Qs/Qt =

Cc´o2 – Cao2

Cc´o2 – Cvo2

Cao2 = Cc´o2 · (1 – Qs/Qt) + (Qs/Qt) · Cvo2

Cvo2 = Cao2 – (Vo2/Qt)

·

Cao2 = Cc´o2 – (Vo2/Qt)

· Qs/Qt10 x (1 – Qs/Qt)(

)

Shunt

Fick

Combined x·

Levin AI. Anesth Analg 2005; 100:12

Page 48: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

C.O. & CaO2: Effect of Shunt

Levin AI, Anesth Analg 2005; 100:12-14

Qs/Qt=0.2, VO2 = 150.

Qs/Qt = 0.4

Page 49: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait
Page 50: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

Optimizing PaO2 during OLV:Beyond CPAP & PEEP ?

Inhaled Nitric Oxide Choice of Volatile Agent Dose of Volatile Agent TIVA Ventilator Mode Position Thoracic Epidural Cardiac Output

Page 51: Optimizing One-Lung  Ventilation Philip  Hartigan , M.D. 11/25/11 Kuwait

THE END